Carbohydrate Antigen 19-9
Carbohydrate antigen 19-9 (CA 19-9), also known as sialyl Lewis A, is a glycolipid and O-linked glycoprotein embedded on the surface of cancer cells. It is synthesized by pancreatic cancer cells and is also produced by normal epithelial cells of the pancreas, bile ducts, stomach, and colon. CA 19-9, as the most commonly used and most effective serum tumor marker, can be used for the diagnosis and treatment of pancreatic cancer in symptomatic patients.
| Cat. No. |
Product Name |
Inquiry |
| XCA-006Q |
Human carbohydrate antigen 19-9 (CA 19-9) from human ascites, Native, 90%
|
|
| XCA-007Q |
Human carbohydrate antigen 19-9 (CA 19-9) from metastatic liver carcinoma, 980 KU/mL
|
|
| XCA-008Q |
Human carbohydrate antigen 19-9 (CA 19-9) from adenocarcinoma cell line supernatants, 42 KU/mL
|
|
| XCA-009Q |
Human carbohydrate antigen 19-9 (CA 19-9) from metastatic liver carcinoma, Native, 90%
|
|
| XCA-031Q |
Human carbohydrate antigen 19-9 (CA 19-9) from metastatic liver carcinoma, Highly purified
|
|
| XCA-032Q |
Human carbohydrate antigen 19-9 (CA 19-9) from colorectal adenocarcinoma cell line, Control grade
|
|
| XCA-033Q |
Human carbohydrate antigen 19-9 (CA 19-9) from gastrointestinal cancer cell culture, Calibrator grade, 70 KU/mL
|
|
| XCA-034Q |
Human carbohydrate antigen 19-9 (CA 19-9) from gastrointestinal cancer cell culture, Calibrator grade, 90 KU/mL
|
|
| XCA-035Q |
Human carbohydrate antigen 19-9 (CA 19-9) from metastatic liver carcinoma, 5,000 KU/mL
|
|
| XCA-036Q |
Human carbohydrate antigen 19-9 (CA 19-9) from liver carcinoma
|
|
| XCA-037Q |
Human carbohydrate antigen 19-9 (CA 19-9) from carcinoma cell line, 100 KU/mL
|
|
| XCA-060Q |
Human carbohydrate antigen 19-9 (CA 19-9) from human ascites, Standard grade
|
|
Resources
